Skip to content
  • Home
  • Team
  • Product Development
    • Matrix3™: Infection Control. Amplified.
    • Hospital Acquired Infections
    • Oncology
  • News
  • Contact
Menu
  • Home
  • Team
  • Product Development
    • Matrix3™: Infection Control. Amplified.
    • Hospital Acquired Infections
    • Oncology
  • News
  • Contact
Read more about the article Ammad Shorbaji

Ammad Shorbaji

VP, Regulatory Affairs

Recent Posts

  • Andira Researcher Dr. Claudia Dietrich wins BEST Oral Presentation at UBC Plastic Surgery Day in Talk About Marix3™ Antimicrobial Technology
  • Andira Pharmaceuticals Appoints Jonathan Primer as Lead Commercial Advisor for Revolutionary Infection Control Technology Matrix3™
  • Andira Pharmaceuticals Achieves Remarkable Breast Cancer Tumor Regression with Lead Oncology Candidate XOXO4
  • Life Sciences Review Magazine Features Andira as Cover Story
  • Andira Pharmaceuticals’ US Patent Allowed in Breakthrough Therapeutic Treatment to Address Deadly Antibiotic-Resistant Infections

Recent Comments

    Archives

    • May 2024
    • March 2024
    • October 2023
    • August 2023
    • March 2023
    • July 2022
    • May 2022
    • March 2022
    • July 2021
    • September 2020
    • August 2020

    Categories

    • Business
    • People
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Categories

    • Business (2)
    • People (1)
    • Uncategorized (13)

    Tags

    press release

    Contact Us

    For media, investors room, further information or other inquiries, please contact us here:

    Contact Us

    Stay In Touch

    Subscribe to our mailing list to receive Andira news releases.

    Copyright © 2024 Andira Pharmaceuticals

    • Home
    • Team
    • Matrix3™: Infection Control. Amplified.
    • Hospital Acquired Infections
    • Oncology
    • News
    • Contact
    • Home
    • Team
    • Matrix3™: Infection Control. Amplified.
    • Hospital Acquired Infections
    • Oncology
    • News
    • Contact